Status: Phase 2
Entry Type: Unknown
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Inflammation Phase 2 ClinicalTrials
Rhinitis; Rhinitis, Allergic Phase 1 ClinicalTrials
CONTENTS